Completed NA INTERVENTIONAL 1-arm NCT00552214

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens

Sponsor: Novartis

Conditions Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Interventions Blood test

Updated 7 times since 2017 Last updated: Feb 17, 2021 Started: Aug 8, 2007 Primary completion: Jul 1, 2008 Completion: Jul 1, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations, this trial is completed. The trial is conducted by Novartis and has accumulated 7 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2021 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Mar 2021 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan